Beatrice Babbs

715 total citations
9 papers, 517 citations indexed

About

Beatrice Babbs is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Beatrice Babbs has authored 9 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Beatrice Babbs's work include Estrogen and related hormone effects (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Beatrice Babbs is often cited by papers focused on Estrogen and related hormone effects (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Beatrice Babbs collaborates with scholars based in United States, China and Canada. Beatrice Babbs's co-authors include Jennifer K. Richer, Melita A. Gordon, Nicholas C. D’Amato, Anthony Elias, Nicole S. Spoelstra, Valerie N. Barton, Britta M. Jacobsen, Dawn R. Cochrane, Benjamin G. Bitler and Michael A. Gordon and has published in prestigious journals such as Development, Cancer Research and Fertility and Sterility.

In The Last Decade

Beatrice Babbs

9 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beatrice Babbs United States	8	267	230	225	180	164	9	517
Adrienne R. Hanson Australia	9	168 0.6×	241 1.0×	106 0.5×	175 1.0×	94 0.6×	15	438
Piiha-Lotta Jerevall Sweden	6	231 0.9×	93 0.4×	143 0.6×	77 0.4×	136 0.8×	8	314
Kimberly Walter United States	3	142 0.5×	129 0.6×	131 0.6×	140 0.8×	98 0.6×	5	297
Suzan Stelloo Netherlands	13	148 0.6×	389 1.7×	141 0.6×	297 1.6×	106 0.6×	23	603
Marianna Sirico Italy	12	129 0.5×	172 0.7×	199 0.9×	125 0.7×	36 0.2×	34	406
Qiji Li China	9	168 0.6×	308 1.3×	131 0.6×	112 0.6×	32 0.2×	13	450
Sonal J. Desai United States	8	95 0.4×	186 0.8×	155 0.7×	210 1.2×	69 0.4×	10	424
Ielizaveta Gorodetska Germany	8	101 0.4×	200 0.9×	122 0.5×	78 0.4×	80 0.5×	13	333
Xu‐Bao Shi United States	8	323 1.2×	375 1.6×	81 0.4×	133 0.7×	43 0.3×	10	498
H. Iwase Japan	7	106 0.4×	204 0.9×	239 1.1×	124 0.7×	221 1.3×	17	447

Countries citing papers authored by Beatrice Babbs

Since Specialization

Citations

This map shows the geographic impact of Beatrice Babbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice Babbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice Babbs more than expected).

Fields of papers citing papers by Beatrice Babbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrice Babbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice Babbs. The network helps show where Beatrice Babbs may publish in the future.

Co-authorship network of co-authors of Beatrice Babbs

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrice Babbs. A scholar is included among the top collaborators of Beatrice Babbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrice Babbs. Beatrice Babbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Babbs, Beatrice, Tomomi M. Yamamoto, Kimberly R. Jordan, et al.. (2024). VDX‐111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression. Molecular Carcinogenesis. 63(7). 1248–1259. 3 indexed citations

Petrache, Irina, Elisabet Pujadas, Aditya Ganju, et al.. (2023). Marked elevations in lung and plasma ceramide in COVID-19 linked to microvascular injury. JCI Insight. 8(10). 14 indexed citations

Gordon, Michael A., Beatrice Babbs, Dawn R. Cochrane, Benjamin G. Bitler, & Jennifer K. Richer. (2018). The long non‐coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2‐mediated alternative splicing. Molecular Carcinogenesis. 58(2). 196–205. 98 indexed citations

Barton, Valerie N., Jessica L. Christenson, Melita A. Gordon, et al.. (2017). Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer. Cancer Research. 77(13). 3455–3466. 54 indexed citations

Gordon, Melita A., Nicholas C. D’Amato, Haihua Gu, et al.. (2017). Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer. Molecular Cancer Therapeutics. 16(7). 1389–1400. 41 indexed citations

D’Amato, Nicholas C., Melita A. Gordon, Beatrice Babbs, et al.. (2016). Cooperative Dynamics of AR and ER Activity in Breast Cancer. Molecular Cancer Research. 14(11). 1054–1067. 105 indexed citations

Heinz, Richard E., Michael C. Rudolph, Palaniappan Ramanathan, et al.. (2016). Constitutive expression of microRNA-150 in mammary epithelium suppresses secretory activation and impairs de novo lipogenesis. Development. 143(22). 4236–4248. 17 indexed citations

Barton, Valerie N., Nicholas C. D’Amato, Melita A. Gordon, et al.. (2015). Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo. Molecular Cancer Therapeutics. 14(3). 769–778. 174 indexed citations

Polotsky, Alex J., Marie Menke, Barbara Isaac, et al.. (2011). Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women. Fertility and Sterility. 95(6). 2063–2066. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact